Virtual clinical trials market by Type and Indication- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 152 Category: Healthcare IT Report Code : HC0114999
Virtual clinical trials market By Type (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular,Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The virtual clinical trials market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Clinical trials are conducted at major research institutions or clinics, often based in urban areas and so to reduce the frequency of study visits to those needed to appropriately monitor safety and efficacy and consider whether flexibility in visit windows is possible and whether electronic communication or through virtual technology tools clinical trials can be used to replace site visits and provide investigators with real-time data.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global virtual clinical trials marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- PRA Health Sciences
- Medidata
- Medpace
- Medable, Inc.
- LEO Innovation Lab
- Clinical Ink
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Virtual clinical trials market , ByType, Estimates and Forecast, 2017-2027 ($Million)
o Interventional
o Observational
o Expanded Access
· Virtual clinical trials market , ByIndication, Estimates and Forecast, 2017-2027 ($Million)
o Oncology
o Cardiovascular
o Others
· Virtual clinical trials market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o PRA Health Sciences
o Medidata
o Medpace
o Medable, Inc.
o LEO Innovation Lab
o Clinical Ink
· Virtual clinical trials market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Virtual clinical trials market , By Country
o U.S. Virtual clinical trials market
o Canada Virtual clinical trials market
o Mexico Virtual clinical trials market
o Europe
§ Europe Virtual clinical trials market , By Country
o UK Virtual clinical trials market
o Germany Virtual clinical trials market
o France Virtual clinical trials market
o Russia Virtual clinical trials market
o Italy Virtual clinical trials market
o Rest of Europe Virtual clinical trials market
o Asia-Pacific
§ Asia-Pacific Virtual clinical trials market , By Country
o China Virtual clinical trials market
o Japan Virtual clinical trials market
o South Korea Virtual clinical trials market
o India Virtual clinical trials market
o Southeast Asia Virtual clinical trials market
o Rest of Asia-Pacific Virtual clinical trials market
o South America
§ South America Virtual clinical trials market
o Brazil Virtual clinical trials market
o Argentina Virtual clinical trials market
o Columbia Virtual clinical trials market
o Rest of South America Virtual clinical trials market
o Middle East and Africa
§ Middle East and Africa Virtual clinical trials market
o Saudi Arabia Virtual clinical trials market
o UAE Virtual clinical trials market
o Egypt Virtual clinical trials market
o Nigeria Virtual clinical trials market
o South Africa Virtual clinical trials market
o TurkeyVirtual clinical trials market
o Rest of MEA Virtual clinical trials market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Virtual Clinical Trials Market, By Type
5.1. Introduction
5.2. Global Virtual Clinical Trials Revenue and Market Share by Type (2017-2021)
5.2.1. Global Virtual Clinical Trials Revenue and Revenue Share by Type (2017-2021)
5.3. Interventional
5.3.1. Global Interventional Revenue and Growth Rate (2017-2021)
5.4. Observational
5.4.1. Global Observational Revenue and Growth Rate (2017-2021)
5.5. Expanded Access
5.5.1. Global Expanded Access Revenue and Growth Rate (2017-2021)
6. Virtual Clinical Trials Market, By Indication
6.1. Introduction
6.2. Global Virtual Clinical Trials Revenue and Market Share by Indication (2017-2021)
6.2.1. Global Virtual Clinical Trials Revenue and Revenue Share by Indication (2017-2021)
6.3. Oncology
6.3.1. Global Oncology Revenue and Growth Rate (2017-2021)
6.4. Cardiovascular
6.4.1. Global Cardiovascular Revenue and Growth Rate (2017-2021)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2021)
7. Virtual Clinical Trials Market, By Region
7.1. Introduction
7.2. Global Virtual Clinical Trials Revenue and Market Share by Regions
7.2.1. Global Virtual Clinical Trials Revenue by Regions (2017-2021)
7.3. North America Virtual Clinical Trials by Countries
7.3.1. North America Virtual Clinical Trials Revenue and Growth Rate (2017-2021)
7.3.2. North America Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Virtual Clinical Trials by Countries
7.4.1. Europe Virtual Clinical Trials Revenue and Growth Rate (2017-2021)
7.4.2. Europe Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Virtual Clinical Trials by Countries
7.5.1. Asia-Pacific Virtual Clinical Trials Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Virtual Clinical Trials by Countries
7.6.1. South America Virtual Clinical Trials Revenue and Growth Rate (2017-2021)
7.6.2. South America Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Virtual Clinical Trials by Countries
7.7.1. Middle East and Africa Virtual Clinical Trials Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. PRA Health Sciences
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Medidata
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Medpace
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Medable, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. LEO Innovation Lab
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Clinical Ink
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
9. Virtual Clinical Trials Market Forecast (2022-2027)
9.1. Global Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Virtual Clinical Trials Market Forecast by Regions (2022-2027)
9.2.1. North America Virtual Clinical Trials Market Forecast (2022-2027)
9.2.1.1. United States Virtual Clinical Trials Market Forecast (2022-2027)
9.2.1.2. Canada Virtual Clinical Trials Market Forecast (2022-2027)
9.2.1.3. Mexico Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2. Europe Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.1. Germany Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.2. France Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.3. UK Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.4. Russia Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.5. Italy Virtual Clinical Trials Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3. Asia-Pacific Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.1. China Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.2. Japan Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.3. Korea Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.4. India Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Virtual Clinical Trials Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Virtual Clinical Trials Market Forecast (2022-2027)
9.2.4. South America Virtual Clinical Trials Market Forecast (2022-2027)
9.2.4.1. Brazil Virtual Clinical Trials Market Forecast (2022-2027)
9.2.4.2. Argentina Virtual Clinical Trials Market Forecast (2022-2027)
9.2.4.3. Columbia Virtual Clinical Trials Market Forecast (2022-2027)
9.2.4.4. Rest of South America Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5. Middle East and Africa Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.3. Egypt Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.4. Nigeria Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.5. South Africa Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.6. Turkey Virtual Clinical Trials Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Virtual Clinical Trials Market Forecast (2022-2027)
9.3. Virtual Clinical Trials Market Forecast by Type (2022-2027)
9.3.1. Virtual Clinical Trials Forecast by Type (2022-2027)
9.3.2. Virtual Clinical Trials Market Share Forecast by Type (2022-2027)
9.4. Virtual Clinical Trials Market Forecast by Indication (2022-2027)
9.4.1. Virtual Clinical Trials Forecast by Indication (2022-2027)
9.4.2. Virtual Clinical Trials Market Share Forecast by Indication (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Virtual Clinical Trials Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Virtual Clinical Trials Revenue and Revenue Share by Type (2017-2019)
Figure Global Interventional Revenue and Growth Rate (2017-2019)
Figure Global Observational Revenue and Growth Rate (2017-2019)
Figure Global Expanded Access Revenue and Growth Rate (2017-2019)
Table Global Virtual Clinical Trials Revenue and Revenue Share by Indication (2017-2019)
Figure Global Oncology Revenue and Growth Rate (2017-2019)
Figure Global Cardiovascular Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Virtual Clinical Trials Revenue by Regions (2017-2019)
Figure North America Virtual Clinical Trials Growth Rate (2017-2019)
Figure North America Virtual Clinical Trials Revenue and Growth Rate (2017-2019)
Figure North America Virtual Clinical Trials by Countries (2017-2019)
Figure North America Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure United States Virtual Clinical Trials Growth Rate (2017-2019)
Figure United States Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Virtual Clinical Trials Growth Rate (2017-2019)
Figure Canada Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Virtual Clinical Trials Growth Rate (2017-2019)
Figure Mexico Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Virtual Clinical Trials Growth Rate (2017-2019)
Figure Europe Virtual Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Europe Virtual Clinical Trials by Countries (2017-2019)
Figure Europe Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Germany Virtual Clinical Trials Growth Rate (2017-2019)
Figure Germany Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Virtual Clinical Trials Growth Rate (2017-2019)
Figure France Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Virtual Clinical Trials Growth Rate (2017-2019)
Figure UK Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Virtual Clinical Trials Growth Rate (2017-2019)
Figure Russia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Virtual Clinical Trials Growth Rate (2017-2019)
Figure Italy Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Virtual Clinical Trials Growth Rate (2017-2019)
Figure Rest of Europe Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Virtual Clinical Trials Growth Rate (2017-2019)
Figure Asia-Pacific Virtual Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Virtual Clinical Trials by Countries (2017-2019)
Figure Asia-Pacific Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure China Virtual Clinical Trials Growth Rate (2017-2019)
Figure China Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Virtual Clinical Trials Growth Rate (2017-2019)
Figure Japan Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Virtual Clinical Trials Growth Rate (2017-2019)
Figure Korea Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Virtual Clinical Trials Growth Rate (2017-2019)
Figure India Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Virtual Clinical Trials Growth Rate (2017-2019)
Figure Southeast Asia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Virtual Clinical Trials Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Virtual Clinical Trials Growth Rate (2017-2019)
Figure South America Virtual Clinical Trials Revenue and Growth Rate (2017-2019)
Figure South America Virtual Clinical Trials by Countries (2017-2019)
Figure South America Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Virtual Clinical Trials Growth Rate (2017-2019)
Figure Brazil Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Virtual Clinical Trials Growth Rate (2017-2019)
Figure Argentina Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Virtual Clinical Trials Growth Rate (2017-2019)
Figure Columbia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Virtual Clinical Trials Growth Rate (2017-2019)
Figure Rest of South America Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Virtual Clinical Trials Growth Rate (2017-2019)
Figure Middle East and Africa Virtual Clinical Trials Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Virtual Clinical Trials by Countries (2017-2019)
Figure Middle East and Africa Virtual Clinical Trials Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Virtual Clinical Trials Growth Rate (2017-2019)
Figure Saudi Arabia Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Virtual Clinical Trials Growth Rate (2017-2019)
Figure United Arab Emirates Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Virtual Clinical Trials Growth Rate (2017-2019)
Figure Egypt Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Virtual Clinical Trials Growth Rate (2017-2019)
Figure Nigeria Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Virtual Clinical Trials Growth Rate (2017-2019)
Figure South Africa Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Virtual Clinical Trials Growth Rate (2017-2019)
Figure Turkey Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Virtual Clinical Trials Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2019)
Table PRA Health Sciences Virtual Clinical Trials Financial Overview
Table Medidata Virtual Clinical Trials Financial Overview
Table Medpace Virtual Clinical Trials Financial Overview
Table Medable, Inc. Virtual Clinical Trials Financial Overview
Table LEO Innovation Lab Virtual Clinical Trials Financial Overview
Table Clinical Ink Virtual Clinical Trials Financial Overview
Figure Global Virtual Clinical Trials Revenue (Millions USD) and Growth Rate (2019-2027)
Table Virtual Clinical Trials Market Forecast by Regions (2019-2027)
Figure North America Virtual Clinical Trials Market Forecast (2019-2027)
Figure United States Virtual Clinical Trials Market Forecast (2019-2027)
Figure Canada Virtual Clinical Trials Market Forecast (2019-2027)
Figure Mexico Virtual Clinical Trials Market Forecast (2019-2027)
Figure Europe Virtual Clinical Trials Market Forecast (2019-2027)
Figure Germany Virtual Clinical Trials Market Forecast (2019-2027)
Figure France Virtual Clinical Trials Market Forecast (2019-2027)
Figure UK Virtual Clinical Trials Market Forecast (2019-2027)
Figure Russia Virtual Clinical Trials Market Forecast (2019-2027)
Figure Italy Virtual Clinical Trials Market Forecast (2019-2027)
Figure Rest of Europe Virtual Clinical Trials Market Forecast (2019-2027)
Figure Asia-Pacific Virtual Clinical Trials Market Forecast (2019-2027)
Figure China Virtual Clinical Trials Market Forecast (2019-2027)
Figure Japan Virtual Clinical Trials Market Forecast (2019-2027)
Figure Korea Virtual Clinical Trials Market Forecast (2019-2027)
Figure India Virtual Clinical Trials Market Forecast (2019-2027)
Figure Southeast Asia Virtual Clinical Trials Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Virtual Clinical Trials Market Forecast (2019-2027)
Figure South America Virtual Clinical Trials Market Forecast (2019-2027)
Figure Brazil Virtual Clinical Trials Market Forecast (2019-2027)
Figure Argentina Virtual Clinical Trials Market Forecast (2019-2027)
Figure Columbia Virtual Clinical Trials Market Forecast (2019-2027)
Figure Rest of South America Virtual Clinical Trials Market Forecast (2019-2027)
Figure Middle East and Africa Virtual Clinical Trials Market Forecast (2019-2027)
Figure Saudi Arabia Virtual Clinical Trials Market Forecast (2019-2027)
Figure United Arab Emirates Virtual Clinical Trials Market Forecast (2019-2027)
Figure Egypt Virtual Clinical Trials Market Forecast (2019-2027)
Figure Nigeria Virtual Clinical Trials Market Forecast (2019-2027)
Figure South Africa Virtual Clinical Trials Market Forecast (2019-2027)
Figure Turkey Virtual Clinical Trials Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Virtual Clinical Trials Market Forecast (2019-2027)
Figure Global Virtual Clinical Trials Forecast by Type (2019-2027)
Figure Global Virtual Clinical Trials Market Share Forecast by Type (2019-2027)
Figure Global Virtual Clinical Trials Forecast by Type (2019-2027)
Figure Global Virtual Clinical Trials Forecast by Indication (2019-2027)
Figure Global Virtual Clinical Trials Market Share Forecast by Indication (2019-2027)
Figure Global Virtual Clinical Trials Forecast by Indication (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|